« Back to Record
Citation APA

Traina, T. T., Miller, K., Yardley, D., Eakle, J., Schwartzberg, L. L., O'Shaughnessy, J., Gradishar, W., Schmid, P., Winer, E., Kelly, C., Nanda, R., Gucalp, A., Awada, A., Garcia-Estevez, L., Trudeau, M. E., Steinberg, J., Uppal, H., Tudor, I. C., Peterson, A., & Cortes, J. (2018). Enzalutamide for the treatment of androgen receptor-expressing triple-negative breast cancer. Journal of clinical oncology, 36(9), 884-890. doi:10.1200/JCO.2016.71.3495


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/279744

Traina, T. T., Miller, K., Yardley, D., Eakle, J., Schwartzberg, L. L., O'Shaughnessy, J., Gradishar, W., Schmid, P., Winer, E., Kelly, C., Nanda, R., Gucalp, A., Awada, A., Garcia-Estevez, L., Trudeau, M. E., Steinberg, J., Uppal, H., Tudor, I. C., Peterson, A., & Cortes, J. (2018). Enzalutamide for the treatment of androgen receptor-expressing triple-negative breast cancer. Journal of clinical oncology, 36(9), 884-890. doi:10.1200/JCO.2016.71.3495